Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 394 Carcinoid Tumor 49 Gastro-enteropancreatic neuroendocrine tumor 42 Neoplasms 36 Carcinoma, Neuroendocrine 36 Adenoma, Islet Cell 27 Neoplasm Metastasis 23 Pancreatic Neoplasms 22 Colorectal Neoplasms 21 Pheochromocytoma 20 Paraganglioma 19 Sarcoma 15 Gastrointestinal Neoplasms 15 Carcinoma 14 Breast Neoplasms 14 Stomach Neoplasms 13 Prostatic Neoplasms 13 Neuroblastoma 13 Lung Neoplasms 13 Carcinoma, Hepatocellular 13 Thyroid Neoplasms 12 Small Cell Lung Carcinoma 12 Carcinoma, Renal Cell 11 Cholangiocarcinoma 10 Neuroectodermal Tumors, Primitive 9 Carcinoma, Non-Small-Cell Lung 9 Somatostatinoma 8 Serotonin Syndrome 8 Digestive System Neoplasms 8 Brain Neoplasms 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Digestive Neuroendocrine Tumors × NET × Clear all

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡